WallStreetZenWallStreetZen

NASDAQ: ARCT
Arcturus Therapeutics Holdings Inc Stock Ownership - Who owns Arcturus Therapeutics Holdings?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arcturus Therapeutics Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andy SassineChief Financial Officer2025-08-151,238$16.56
$20.50kBuy
Andy SassineChief Financial Officer2025-08-151,238$16.56
$20.50kBuy
Andy SassineChief Financial Officer2025-08-151,238$16.56
$20.50kBuy

1 of 1

ARCT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARCT insiders and whales buy or sell their stock.

ARCT Shareholders

What type of owners hold Arcturus Therapeutics Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Federated Hermes Inc17.29%4,694,060$40.56MInstitution
Blackrock Inc9.73%2,641,268$22.82MInstitution
Sumitomo Mitsui Trust Group Inc6.75%1,832,467$15.83MInstitution
Nikko Asset Management Americas Inc6.74%1,830,203$15.81MInstitution
Vanguard Group Inc6.67%1,810,165$15.64MInstitution
Ark Investment Management LLC6.32%1,715,040$14.82MInstitution
Joseph E. Payne5.45%1,480,097$12.79MInsider
Ultragenyx Pharmaceutical Inc5.16%1,400,000$12.10MInsider
State Street Corp3.76%1,019,774$8.81MInstitution
Balyasny Asset Management LP3.18%864,096$7.47MInstitution

1 of 3

ARCT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARCT87.48%12.52%Net BuyingNet Buying
CLLS16.23%0.00%
ENTA56.45%43.55%Net SellingNet Selling
ZURA45.32%54.68%Net Selling
IMRX10.54%38.75%Net BuyingNet Buying
View Top Biotech Stocks

Arcturus Therapeutics Holdings Stock Ownership FAQ

Who owns Arcturus Therapeutics Holdings?

Arcturus Therapeutics Holdings (NASDAQ: ARCT) is owned by 94.89% institutional shareholders, 13.58% Arcturus Therapeutics Holdings insiders, and 0.00% retail investors. Joseph E. Payne is the largest individual Arcturus Therapeutics Holdings shareholder, owning 1.48M shares representing 5.45% of the company. Joseph E. Payne's Arcturus Therapeutics Holdings shares are currently valued at $12.79M.

If you're new to stock investing, here's how to buy Arcturus Therapeutics Holdings stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.